MAPK3 and cardiac hypertrophy: To further examine the mechanism by which rapamycin attenuates cardiac hypertrophy, H9C2 cells were treated with or without rapamycin and the MEK inhibitor PD98059, and the activity of the MEK/ERK1/2 pathway and the expression of autophagy markers were assessed by western blotting.